Denise Kelly
Investment Advisor Seventure Partners
Dr. Denise Kelly is an Investment Advisor at Seventure Partners, where she focuses on microbiome-related investments through the Health for Life Capital™ fund. With over 20 years of experience in gut microbiology, Denise previously served as Head of Research at the Rowett Institute and founded GT Biologics, a company dedicated to microbiome therapeutics. She brings deep scientific expertise and strategic insight to support early-stage companies developing innovative solutions in health and nutrition. Denise is passionate about translating microbiome science into impactful products that improve human health.
Seminars
- Highlight data-driven milestones that attract funding to unlock capital
- Structure deals to balance risk and reward for early-stage ventures to improve term-sheet appeal
- Position platforms for scalability and exit potential to attract strategic investment
This dynamic session offers a platform for early-stage microbiome companies to pitch their technologies to a panel of investors, pharma scouts, and industry experts. Designed to foster visibility, feedback, and potential partnerships, each presentation is followed by live commentary and audience engagement.
